Showing results (131-140 of 313) with videos related to
Sort By:
Pageof 32
Diabetes Care|December 17, 2009
Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucoseMuhammad A Abdul-Ghani, Michael P Stern, Valeriya Lyssenko, et al.Diabetes|June 15, 2017
Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting GlucoseMuhammad Abdul-Ghani, Hussein Al Jobori, Giuseppe Daniele, et al.Diabetes Care|February 25, 2011
The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology studyMustafa Kanat, Diedre Winnier, Luke Norton, et al.Diabetes Care|September 28, 2006
The effect of pioglitazone on the liver: role of adiponectinAmalia Gastaldelli, Yoshinori Miyazaki, Archana Mahankali, et al.The Journal of Clinical Endocrinology and Metabolism|November 5, 2002
Metabolic effects of visceral fat accumulation in type 2 diabetesAmalia Gastaldelli, Yoshinori Miyazaki, Maura Pettiti, et al.American Journal of Physiology. Endocrinology and Metabolism|April 19, 2012
Effect of acute exercise on glycogen synthase in muscle from obese and diabetic subjectsJørgen Jensen, Puntip Tantiwong, Jorid T Stuenæs, et al.Diabetes Care|April 13, 2013
Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer studyCarolina Solis-Herrera, Curtis Triplitt, Jose de Jesús Garduno-Garcia, et al.Diabetes, Obesity & Metabolism|January 28, 2017
Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patientsHussein Al Jobori, Giuseppe Daniele, John Adams, et al.Diabetes Care|June 3, 2009
Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistanceAlberto O Chavez, Marjorie Molina-Carrion, Muhammad A Abdul-Ghani, et al.Diabetes|September 28, 2002
Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetesMandeep Bajaj, Thongchai Pratipanawatr, Rachele Berria, et al.Pageof 32